» Articles » PMID: 28786749

Specificities of the Intestinal Microbiota in Patients with Inflammatory Bowel Disease and Clostridium Difficile Infection

Abstract

Clostridium difficile infection (CDI) is a common complication in inflammatory bowel disease (IBD) and has been associated with poor IBD outcome. Intestinal microbiota composition in IBD patients with CDI has not been specifically evaluated to date. The fecal microbiota of 56 IBD patients, including 8 in flare with concomitant CDI, 24 in flare without CDI, and 24 in remission, as well as 24 healthy subjects, was studied using 16S sequencing. Analysis was performed using the Qiime pipeline. Compared to IBD patients without CDI, IBD patients with CDI had more pronounced dysbiosis with higher levels of Ruminococcus gnavus and Enterococcus operational taxonomic units (OTUs) and lower levels of Blautia and Dorea OTUs. Correlation network analysis suggested a disrupted ecosystem in IBD patients in flare, particularly in those with CDI. In patients with IBD, CDI is associated with a more pronounced intestinal dysbiosis with specific alterations in intestinal microorganisms.

Citing Articles

infection is associated with differences in transcriptionally active microbial communities.

Chen See J, Leister J, Wright J, Kruse P, Khedekar M, Besch C Front Microbiol. 2024; 15:1398018.

PMID: 38680911 PMC: 11045941. DOI: 10.3389/fmicb.2024.1398018.


Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.

Hertz S, Anderson J, Nielsen H, Schachtschneider C, McCauley K, Ozcam M Ann Med. 2024; 56(1):2338244.

PMID: 38648495 PMC: 11036898. DOI: 10.1080/07853890.2024.2338244.


Gut Microbiome-Related Anti-Inflammatory Effects of Aryl Hydrocarbon Receptor Activation on Inflammatory Bowel Disease.

Moutusy S, Ohsako S Int J Mol Sci. 2024; 25(6).

PMID: 38542367 PMC: 10970487. DOI: 10.3390/ijms25063372.


An Update on the Role and Potential Molecules in Relation to in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus.

Hong J, Fu T, Liu W, Du Y, Bu J, Wei G Diabetes Metab Syndr Obes. 2024; 17:1235-1248.

PMID: 38496006 PMC: 10942254. DOI: 10.2147/DMSO.S456173.


Specific Alternation of Gut Microbiota and the Role of in the Development of Diabetic Nephropathy.

Hong J, Fu T, Liu W, Du Y, Bu J, Wei G J Microbiol Biotechnol. 2024; 34(3):547-561.

PMID: 38346799 PMC: 11016775. DOI: 10.4014/jmb.2310.10028.


References
1.
Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett W . Metagenomic biomarker discovery and explanation. Genome Biol. 2011; 12(6):R60. PMC: 3218848. DOI: 10.1186/gb-2011-12-6-r60. View

2.
Willing B, Dicksved J, Halfvarson J, Andersson A, Lucio M, Zheng Z . A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology. 2010; 139(6):1844-1854.e1. DOI: 10.1053/j.gastro.2010.08.049. View

3.
Morgan X, Tickle T, Sokol H, Gevers D, Devaney K, Ward D . Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012; 13(9):R79. PMC: 3506950. DOI: 10.1186/gb-2012-13-9-r79. View

4.
Ananthakrishnan A, McGinley E, Saeian K, Binion D . Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2010; 17(4):976-83. DOI: 10.1002/ibd.21457. View

5.
van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W . Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-15. DOI: 10.1056/NEJMoa1205037. View